Nanomedicine and ethics: Is there anything new or unique?

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 3, Issue 2, 2011, Pages 111-118

  Kuiken, Todd ^a  

^a WOODROW WILSON INTERNATIONAL CENTER FOR SCHOLARS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHICAL ISSUES; ETHICAL QUESTION; HEALTH CARE PROFESSIONALS; HUMAN CAPABILITY; MEDICAL DEVICES; MEDICAL INFORMATION; NANOMEDICINES; NEW TECHNOLOGIES; POTENTIAL PROBLEMS; PUBLIC ACCEPTANCE;

HEALTH CARE; HEALTH RISKS; HUMAN COMPUTER INTERACTION; MEDICAL NANOTECHNOLOGY;

PHILOSOPHICAL ASPECTS;

DNA DETERMINATION; DRUG INDUSTRY; DRUG MARKETING; HUMAN; INFECTION RISK; MEDICAL ETHICS; MEDICAL INFORMATION; NANOMEDICINE; PRIORITY JOURNAL; REVIEW; ETHICS;

HUMANS; NANOMEDICINE;

EID: 79551705641     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.90     Document Type: Review

References (38)

1. The NIH Common Fund: Nanomedicine. Available at: Accessed December 11, 2009.
2. Nazarov GV, Galan SE, Nazarova EV, Karkishchenko NN, Muradov MM, et al. Drug synthesis methods and manufacturing technology: nanosized forms of drugs (a review). Pharm Chem J 2009, 43: 163-170.
3. Wagner V, Dullaart A, Bock AK, Zweck A. The emerging nanomedicine landscape. Nat Biotechnol 2006, 24: 1211-1217.
4. Culliton BJ. Is special FDA regulation of nanomedicine needed? A conversation with Norris E. Alderson. Health Aff 2008, 27: w315-w317.
5. Riehemann K, Schneider SW, Luger TA, Godin B, Ferrari M, et al. Nanomedicine-challenges and perspectives. Angew Chem Int Ed 2009, 48: 872-897.
6. Sandhiya S, Aibor Dkhar S, Surendiran A. Emerging trends of nanomedicine -an overview. Fundam Clin Pharmacol 2009, 23: 263-269.
7. Moghimi SM, Hunter AC, Murray JC. Nanomedicine: current status and future prospects. FASEB J 2005, 19: 311-330.
8. Gordijn B. Nanoethics: from utopian dreams and apocalyptic nightmares towards a more balanced view. Sci Eng Ethics 2005, 11: 521-533.
9. Resnik DB, Tinkle SS. Ethics in nanomedicine. Nanomedicine 2007, 2: 345-350.
10. Spagnolo AG, Daloiso V. Outlining ethical issues in nanotechnologies. Bioethics 2008, 23: 394-402.
11. Evers J, Aerts S, De Tavernier J. An ethical argument in favor of nano-enabled diagnostics in livestock disease control. Nanoethics 2008, 2: 163-178.
12. European Group of Ethics in Science and new Technologies. Ethical aspects of ICT implants in the human body. Opinion no. 20. 2005. Available at: Accessed December 9, 2009.
13. The European Group on Ethics in Science and New Technologies to the European Commission. Opinion on the ethical issues aspects of nanomedicine. Opinion no. 21. 2007. Available at: Accessed April 12, 2010.
14. Resnik DB, Tinkle SS. Ethical issues in clinical trials involving nanomedicine. Contemp Clin Trials 2007, 28: 433-441.
15. Criteria for IRB approval of research. 21 C.F.R. 56.111 (1998). See also 45 C.F.R. 46.111 2005.
16. Ferrari M, Philibert MA, Sanhai WR. Nanomedicine and society. Clin Pharmacol Ther 2009, 85: 466-467.
17. Khushf G. Upstream ethics in nanomedicine: a call for research. Nanomedicine 2007, 2: 511-521.
18. White GB. Missing the boat on nanoethics. Am J Bioeth 2009, 9: 18-19.
19. Sparrow R. Revolutionary and familiar, inevitable and precarious: rhetorical contradictions in enthusiasm for nanotechnology. Nanoethics 2007, 1: 57-68.
20. Lewenstein BV. What counts as a "Social and Ethical Issue" in nanotechnology? HYLE-Int J Philos Chem 2005, 11: 5-18.
21. Satava RM. Disruptive visions: moral and ethical challenges from advanced technology and issues for the new generation of surgeons. Surg Endosc 2002, 16: 1403-1408.
22. Mnyusiwalla A, Daar AS, Singer PA. Mind the gap: science and ethics in nanotechnology. Nanotechnology 2003, 14: R9-R13.
23. Lenk C, Biller-Andorno N. Nanomedicine-emerging or re-emerging ethical issues? A discussion of four ethical themes. Med Health Care Philos 2007, 10: 173-184.
24. Preston CJ. The promise and threat of nanotechnology. HYLE-Int J Philos Chem 2005, 11: 19-44.
25. Sandler R. Nanomedicine and nanomedical ethics. Am J Bioeth 2009, 9: 16-17.
26. Allhoff F. The coming era of nanomedicine. Am J Bioeth 2009, 9: 3-11.
27. Johnson S. The era of nanomedicine and nanoethics: has it come, is it still coming, or will it pass us by? Am J Bioeth 2009, 9: 1-2.
28. McGee EM. Nanomedicine: ethical concerns beyond diagnostics, drugs, and techniques. Am J Bioeth 2009, 9: 14-15.
29. Bawa R, Johnson S. The ethical dimensions of nanomedicine. Med Clin North Am 2007, 91: 881-887.
30. Grunwald A. Nanotechnology -a new field of ethical inquiry?. Sci Eng Eth 2005, 11: 187-201.
31. Godman M. But is it unique to nanotechnology? Reframing nanoethics. Sci Eng Eth 2008, 14: 391-403.
32. Petersen A. Introduction: the ethical challenges of nanotechnologies. Bioeth Inq 2009, 6: 9-12.
33. Sparrow R. The social impacts of nanotechnology: an ethical and political analysis. Bioeth Inq 2009, 6: 13-23.
34. MacDonald C. Nanotech is novel; the ethical issues are not. The Scientist 2004, 18: 3.
35. Awareness Hart Research Associates. of and attitudes toward nanotechnology and synthetic biology. A report of findings based on a national survey among adults. Conducted on behalf of Project on Emerging Nanotechnologies. 2008. Available at: Accessed April 12, 2010.
36. Hart Research Associates. Nanotechnolgy, Synthetic Biology, & Public Opinion. A report of fundings. Based on a national survey among adults. Conducted on behalf of Project on Emerging Nanotechnologies. 2009. Available at: Accessed April 12, 2010.
37. Cameron NMS. Nanotechnology and the human future: policy, ethics, and risk. Ann NY Acad Sci 2006, 1093: 280-300.
38. Guerra G. European regulatory issues in nanomedicine. Nanoethics 2008, 2: 87-97.